VRUS – Roadmap of R7128 results in phase-1 combination study with peg-ifn and ribavirin.<pre> Dose HCV Trtmnt iHub Cohort (BID) Genotype Line Reference 1 500mg 1 1st <a href='read_msg.asp?message_id=28837612'>#msg-28837612</a> 2 1500mg 1 1st <a href='read_msg.asp?message_id=28837612'>#msg-28837612</a> 3 1000mg 1 1st <a href='read_msg.asp?message_id=31218459'>#msg-31218459</a> 4 1500mg 2/3 2nd <a href='read_msg.asp?message_id=31999860'>#msg-31999860</a></pre>